3 Stocks I Saw on T...
Health Care: Drugs
Akorn Inc. (AKRX: NASDAQ)
$13.75 0.45 | 3.38%
06/04/12 - 02:55 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 30.90 | 41.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 1.10 | 0.46 | 0.98 |
| Price to Sales (TTM) | 7.75 | 2.04 | 1.42 |
| Price to Book (MRQ) | 7.54 | 2.63 | 2.41 |
| Price to Tangible Book (MRQ) | 30.39 | -21.74 | 5.08 |
| Price to Cash Flow (TTM) | 22.80 | 17.80 | 9.80 |
| Price to Free Cash Flow (TTM) | -9.10 | 38.30 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.60 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.30 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 0.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 103.30 | 14.20 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 58.50 | 10.80 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 19.49 | 19.65 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 46.20 | 116.90 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 46.20 | 116.90 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 1.26 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 63.40 | -1.90 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.80 | 1.10 | 1.10 |
| Current Ratio (MRQ) | 3.30 | 1.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.69 | 0.69 | 0.82 |
| Total Debt to Equity (MRQ) | 0.69 | 0.81 | 0.96 |
| Interest Coverage (TTM) | 8.30 | 2.80 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 63.20 | 49.40 | 46.90 |
| Gross Margin - 5 Yr Avg | 44.80 | 46.00 | 47.70 |
| EBITD Margin (TTM) | 32.70 | 20.70 | 18.90 |
| EBITD - 5 Yr Avg | 5.57 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 29.70 | 7.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 2.40 | 0.50 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.28 | 0.06 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 2.80 | -1.70 | 7.00 |
| Return on Assets (TTM) | 14.10 | 3.20 | 3.10 |
| Return on Assets - 5 Yr Avg | 1.90 | -0.80 | 2.50 |
| Return on Investment (TTM) | 16.10 | 4.50 | 7.90 |
| Return on Investment - 5 Yr Avg | 2.30 | -1.10 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 295,105.00 | 609,034.00 | 449,376.00 |
| Net Income/Employee (TTM) | 82,631.00 | 36,701.00 | 39,003.00 |
| Receivable Turnover (TTM) | 7.10 | 4.70 | 7.60 |
| Inventory Turnover (TTM) | 2.00 | 2.70 | 8.30 |
| Asset Turnover (TTM) | 0.70 | 0.60 | 0.40 |
Portfolios with AKRX
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 16
- UserGFNN Stockdiagnostics 11
- Userpharmacy
- UserGFNN Stockdiagnostics 4
- UserDIGGITY PORTFOLIO
- UserGFNN Stockdiagnostics
- ContributorStocks At New 52-Week Highs...
- UserDivatrades
- Contributor5 Stocks Under-$10 Setting ...
- UserMister 600
Latest AKRX Headlines from TheStreet
- Akorn Stock Hits New 52-Week High (AKRX) 05.30.12 | 02:05 pm
- 3 Stocks Hit 52-Week Highs 05.15.12 | 02:05 pm
- Akorn Stock Hits New 52-Week High (AKRX) 05.15.12 | 09:05 am
- Akorn Reaches New 52-Week High (AKRX) 02.29.12 | 10:02 am
- Akorn Rises On Unusually High Volume (AKRX) 02.13.12 | 04:02 pm
- 3 Stocks Hitting 52-Week Highs: Akorn, Sunoco Logistics, Cincinnati Financial 02.10.12 | 02:02 pm
- Akorn Reaches New 52-Week High (AKRX) 02.10.12 | 12:02 pm
- Akorn Reaches New 52-Week High (AKRX) 02.01.12 | 09:02 am
- Akorn Reaches New 52-Week High (AKRX) 12.19.11 | 10:12 am
- 6 Stocks at New 52-Week Highs 12.13.11 | 01:12 pm
Press Releases for AKRX
- Akorn Reports Record First Quarter 2012 Financial Results - Business Wire 05.08.12 | 06:05 am
- Akorn Announces The Approval And Launch Of Generic Vancocin® - Business Wire 04.10.12 | 06:04 am
- Brinson Patrick Securities Initiates Research Coverage Of Akorn, Inc. - PR Newswire 03.22.12 | 03:03 pm
- Akorn Reports 2011 Fourth Quarter And Year-End Financial Results - Business Wire 03.06.12 | 07:03 am
- Akorn Announces The Appointment Of Dr. Adrienne Graves, Ph.D. To Its Board Of Directors - Business Wire 03.05.12 | 08:03 pm
- Akorn Completes The Acquisition Of Certain Assets Of Kilitch Drugs In India - Business Wire 02.28.12 | 07:02 pm
- Akorn Provides Financial Guidance For 2012 - Business Wire 01.17.12 | 07:01 am
- Akorn Acquires Three Hospital-Based Branded Injectables From Lundbeck - Business Wire 12.22.11 | 01:12 pm
- Akorn Reports Record Third Quarter 2011 Financial Results - Business Wire 11.01.11 | 07:11 am
- Akorn Enters Into An Agreement To Acquire Certain Assets Of Kilitch Drugs In India - Business Wire 10.06.11 | 12:10 am
Partner Headlines for AKRX
- Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Press Releases - Zacks 02.08.12 | 09:02 am
- Akorn, Inc. - Momentum - Zacks 02.08.12 | 01:02 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.20.12 | 09:01 am
- End-of-Day Market Summary for December 23, 2011 - Benzinga 12.23.11 | 04:12 pm
- Hearing Akorn Recent Weakness Attributed to FDA Inspection Letter - Benzinga 12.23.11 | 11:12 am
- Akorn Acquires Three Hospital-Based Branded Injectables from Lundbeck; Expected To Add Approximately $30-$35M in 2012 - Benzinga 12.22.11 | 01:12 pm
- Piper Jaffray Maintains Overweight, $12 Target on Akorn - Benzinga 12.15.11 | 09:12 am
- Akorn, Inc - Aggressive Growth - Zacks 11.11.11 | 01:11 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.03.11 | 09:11 am
- These NASDAQ Rockets Should Be In Your Portfolio - Seeking Alpha 10.19.11 | 09:10 am
